1303571-60-9Relevant academic research and scientific papers
N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation
Granchi, Carlotta,Roy, Sarabindu,De Simone, Alessio,Salvetti, Irene,Tuccinardi, Tiziano,Martinelli, Adriano,MacChia, Marco,Lanza, Mario,Betti, Laura,Giannaccini, Gino,Lucacchini, Antonio,Giovannetti, Elisa,Sciarrillo, Rocco,Peters, Godefridus J.,Minutolo, Filippo
, p. 5398 - 5407 (2011/12/14)
Current cancer research is being increasingly focused on the study of distinctive characters of tumour metabolism, resulting in a switch from oxidative phosphorylation to glycolysis (Warburg effect). Isoform 5 of human lactate dehydrogenase (hLDH5), which
COMPOUNDS INHIBITORS OF ENZYME LACTATE DEHYDROGENASE (LDH) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
-
Page/Page column 35-39, (2011/06/11)
The present invention concerns compounds, some of which are novel, and their pharmaceutical applications. The compounds of the invention inhibit the enzyme lactate dehydrogenase (LDH) involved both in the metabolic process of hypoxic tumour cells, and in the process used by parasitic protozoa that cause malaria to obtain most of the energy they need.
